THE MOLECULAR-BASIS FOR EPITOPES ON THE FREE BETA-SUBUNIT OF HUMAN CHORIONIC-GONADOTROPIN (HCG), ITS CARBOXYL-TERMINAL PEPTIDE AND THE HCG-BETA-CORE FRAGMENT

被引:46
|
作者
DIRNHOFER, S
MADERSBACHER, S
BIDART, JM
TENKORTENAAR, PBW
SPOTTL, G
MANN, K
WICK, G
BERGER, P
机构
[1] AUSTRIAN ACAD SCI,INST BIOMED AGING RES,A-6020 INNSBRUCK,AUSTRIA
[2] INST GUSTAVE ROUSSY,DEPT BIOL CLIN,F-94805 VILLEJUIF,FRANCE
[3] DIOSYNTH INT BV,AKZO,OSS,NETHERLANDS
[4] UNIV MUNICH,KLINIKUM GROSSHADERN,DEPT MED 2,W-8000 MUNICH,GERMANY
关键词
D O I
10.1677/joe.0.1410153
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The molecular basis for antigenic determinants on the free beta-subunit of human chorionic gonadotrophin (hCG beta), its carboxyl-terminal peptide (hCG beta CTP) and the hCG beta-core fragment (hCG beta cf) was elucidated by means of monoclonal antibodies (MCAs). The objective of the present study was to resolve the antigenic topography of these three molecules in terms of epitope identification at different levels of structural organization as well as analysis of their spatial arrangement. An hCG beta cf preparation, a synthetic peptide corresponding to the hCG beta CTP (beta 109-145), overlapping synthetic peptides spanning the entire amino acid sequence of hCG beta, and a reduced and alkylated hCG beta preparation were assayed in a solid-phase one-site enzyme-linked immunoassay and in a soluble-phase direct-binding radioimmunoassay (RIA) or competitive RIA. The antigenic topography was mapped by incorporating the MCAs into two-site binding assays. On the surface of free hCG beta, nine different epitopes (beta(1)-beta(9)), arranged in three spatially distinct domains, could be distinguished. Epitopes beta(1)-beta(7) were located in a single large domain on both hCG beta and the hCG beta cf whereas hCG beta CTP contained two topographically distant determinants, designated beta(8) and beta(9) respectively. All but the two epitopes located on hCG beta CTP (beta(8) and beta(9)) were destroyed by reducing and alkylating hCG beta, suggesting that most antigenic determinants are predominantly noncontiguous and require an intact tertiary structure whereas the molecular structure of hCG beta CTP is Linear. At a molecular level, amino acid residues spanning hCG beta 45-52, hCG beta 137-144 and hCG beta 113-116 contributed to the formation of epitopes beta(5), beta(8), and beta(9) respectively. We have also shown that the hCG beta cf represents the immuno-dominant part of the free beta-subunit of hCG, containing seven mainly conformationally determined epitopes, one of which has a share of the sequence beta 45-52. The hCG beta CTP does not play a critical role in the immunologically important tertiary structure of hCG beta and was itself found to be a predominantly continuous sequence also within the native hormone, expressing two spatially distant antigenic determinants located within residues beta 113-116 and beta 137-144 respectively.
引用
收藏
页码:153 / 162
页数:10
相关论文
共 50 条
  • [21] REGULATION OF THE INTRACELLULAR AND IN-VITRO FOLDING OF HUMAN CHORIONIC-GONADOTROPIN (HCG) BETA-SUBUNIT AND ITS ASSEMBLY WITH ALPHA
    RUDDON, RW
    BEDOWS, E
    FENG, W
    HUTH, JR
    BOIME, I
    FASEB JOURNAL, 1995, 9 (06): : A1249 - A1249
  • [22] BACTERIAL EXPRESSION AND IN-VITRO FOLDING OF THE BETA-SUBUNIT OF HUMAN CHORIONIC-GONADOTROPIN (HCG-BETA) AND FUNCTIONAL ASSEMBLY OF RECOMBINANT HCG-BETA WITH HCG-ALPHA
    HUTH, JR
    NORTON, SE
    LOCKRIDGE, O
    SHIKONE, T
    HSUEH, AJW
    RUDDON, RW
    ENDOCRINOLOGY, 1994, 135 (03) : 911 - 918
  • [23] IMMUNOLOGICAL PROPERTIES OF THE BETA-SUBUNIT OF HUMAN CHORIONIC-GONADOTROPIN (HCG) .2. PROPERTIES OF A HCG-SPECIFIC ANTIBODY PREPARED AGAINST A CHEMICAL ANALOG OF THE BETA-SUBUNIT
    PANDIAN, MR
    MITRA, R
    BAHL, OP
    ENDOCRINOLOGY, 1980, 107 (05) : 1564 - 1571
  • [24] URINARY HUMAN CHORIONIC-GONADOTROPIN FREE BETA-SUBUNIT AND BETA-CORE FRAGMENT - A NEW MARKER OF GYNECOLOGICAL CANCERS
    COLE, LA
    WANG, YX
    ELLIOTT, M
    LATIF, M
    CHAMBERS, JT
    CHAMBERS, SK
    SCHWARTZ, PE
    CANCER RESEARCH, 1988, 48 (05) : 1356 - 1360
  • [25] FREE ALPHA-SUBUNIT, FREE BETA-SUBUNIT OF HUMAN CHORIONIC-GONADOTROPIN (HCG), AND INTACT HCG IN SERA OF HEALTHY-INDIVIDUALS AND TESTICULAR CANCER-PATIENTS
    MADERSBACHER, S
    KLIEBER, R
    MANN, K
    MARTH, C
    TABARELLI, M
    WICK, G
    BERGER, P
    CLINICAL CHEMISTRY, 1992, 38 (03) : 370 - 376
  • [26] HUMAN CHORIONIC-GONADOTROPIN .4. SYNTHESIS OF A HEXADECAPEPTIDE CORRESPONDING TO THE C-TERMINAL SEQUENCE 130-145 OF THE BETA-SUBUNIT OF HUMAN CHORIONIC-GONADOTROPIN (HCG)
    OKADA, Y
    IGUCHI, S
    MIMURA, M
    KAWASAKI, K
    YAMAJI, K
    TAKAGI, T
    TANIZAWA, O
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1980, 28 (09) : 2707 - 2713
  • [27] HUMAN CHORIONIC-GONADOTROPIN .2. SYNTHESIS OF A HEXADECAPEPTIDE CORRESPONDING TO THE C-TERMINAL SEQUENCE 132-147 OF THE BETA-SUBUNIT OF HUMAN CHORIONIC-GONADOTROPIN (HCG)
    KAWASAKI, K
    KAWASAKI, C
    TSUDA, Y
    MAEDA, M
    OKADA, Y
    YAMAJI, K
    TAKAGI, T
    TANIZAWA, O
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1980, 28 (09) : 2692 - 2698
  • [28] HUMAN CHORIONIC-GONADOTROPIN .3. SYNTHESIS OF A DOTRIACONTAPEPTIDE CORRESPONDING TO THE C-TERMINAL SEQUENCE 116-147 OF THE BETA-SUBUNIT OF HUMAN CHORIONIC-GONADOTROPIN (HCG)
    KAWASAKI, K
    KAWASAKI, C
    TSUDA, Y
    YAGYU, M
    OKADA, Y
    YAMAJI, K
    TAKAGI, T
    TANIZAWA, O
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1980, 28 (09) : 2699 - 2706
  • [29] HUMAN CHORIONIC-GONADOTROPIN .6. SYNTHESIS OF A TETRATRIACONTAPEPTIDE CORRESPONDING TO THE C-TERMINAL SEQUENCE 112-145 OF THE BETA-SUBUNIT OF HUMAN CHORIONIC-GONADOTROPIN (HCG)
    OKADA, Y
    KAWASAKI, K
    IGUCHI, S
    YAGYU, M
    YAMAJI, K
    TAKAGI, T
    SUGITA, N
    TANIZAWA, O
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1981, 29 (10) : 2851 - 2855
  • [30] HUMAN CHORIONIC-GONADOTROPIN .5. SYNTHESIS OF A TRIACONTAPEPTIDE CORRESPONDING TO THE C-TERMINAL SEQUENCE 116-145 OF THE BETA-SUBUNIT OF HUMAN CHORIONIC-GONADOTROPIN (HCG)
    OKADA, Y
    IGUCHI, S
    YAGYU, M
    KAWASAKI, K
    YAMAJI, K
    TAKAGI, T
    TANIZAWA, O
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1980, 28 (09) : 2714 - 2719